Restrictive abortion laws, COVID-19, telehealth, and medication abortion in the SDG era.

Awowole, Ibraheem O; Ijarotimi, Omotade A

Awowole, Ibraheem O; Ijarotimi, Omotade A.

Awowole IO; Department of Obstetrics, Gynaecology and Perinatology, Obafemi Awolowo University, Ife 220005, Nigeria; Department of Obstetrics and Gynaecology, Obafemi Awolowo University Teaching Hospitals Complex, Ife, Nigeria. Electronic address: iawowole@oauife.edu.ng.
Ijarotimi OA; Department of Obstetrics, Gynaecology and Perinatology, Obafemi Awolowo University, Ife 220005, Nigeria; Department of Obstetrics and Gynaecology, Obafemi Awolowo University Teaching Hospitals Complex, Ife, Nigeria.

Lancet Glob Health ; 10(1): e14-e15, 2022 01.

Article in English | MEDLINE | ID: covidwho-1586168

Subject(s)

Abortifacient Agents/therapeutic use; Abortion, Induced/legislation & jurisprudence; COVID-19; Telemedicine; Abortion, Legal; Female; Humans; Pregnancy; Sustainable Development

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Abortifacient Agents / Abortion, Induced / Telemedicine / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Female / Humans / Pregnancy Language: English Journal: Lancet Glob Health Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google